A Phase 2 study of TRL1068 in prosthetic joint infections

Active, Not Recruiting Phase 2 NCT06621251

Study Description

A study evaluating the effectiveness and safety of TRL1068 in treating prosthetic joint infections and avoiding the need for joint replacement surgery

Study Details

Registry ID:: NCT06621251
Conditions:: Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee
Phase:: Phase 2
Target Enrollment:: 60 participants
Start Date:: April 8, 2025
Age Range:: 18–85 years
Healthy Volunteers:: No

Study Locations (17 sites)

New England Baptist Hospital
Boston, MassachusettsUnited States, United States
Phoenix Clinical Research
Tamarac, FloridaUnited States, United States
NYU Langone Health
New York, New YorkUnited States, United States
M3 Wake Research Associates
Wilmington, North CarolinaUnited States, United States
Sinai Hospital Baltimore
Baltimore, MarylandUnited States, United States
Gulfcoast Research Institute
Sarasota, FloridaUnited States, United States
Mayo Clinic Jacksonville
Jacksonville, FloridaUnited States, United States
University of Rochester
Rochester, New YorkUnited States, United States
University of Arkansas for Medical Sciences (UAMS)
Little Rock, ArkansasUnited States, United States
University of Texas Medical Branch at Galveston
Galveston, TexasUnited States, United States
Houston Methodist
Houston, TexasUnited States, United States
Paradigm Research Center
Houston, TexasUnited States, United States
Proactive RGV
Brownsville, TexasUnited States, United States
North Texas Medical Research Institute
Rockwall, TexasUnited States, United States
OrthoArizona
Gilbert, ArizonaUnited States, United States
University of Utah
Salt Lake City, UtahUnited States, United States
UCLA
Los Angeles, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →